United States · Health startup
United States · Aavia
Aavia is a digital health company focused on hormone health for Gen-Z and young adults.
Funding reportedLast round: Seed
About Aavia
Aavia is a digital health company focused on hormone health for Gen-Z and young adults.
Founded in 2017, Aavia offers a daily hormone health app and a patented smart pill case designed to help individuals with ovaries track their hormonal symptoms and adhere to birth control. The app allows users to log daily symptoms and receive personalized insights, while the smart pill case provides reminders to ensure users take their medication on time. The company aims to destigmatize hormone health and empower users through data-driven insights. Aavia also provides educational content on ovarian hormones and connects users with a supportive community of peers and medical experts. With a team of around 12 employees, Aavia operates primarily out of New York, NY, and has raised approximately $6.95M–$7M in funding from various investors.
What company datasets say Aavia raised
Funding, as reported
On 5 portfolio pages
Investors who name them
Each firm lists Aavia on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health trend reportshospital & health carewellness & fitness serviceshealth carepatient data controlhormone health researchmedical advisory boardappscycle syncingdigital healthclinical supportapp developmentconsumer appfertility planning supportmobile appscommunity
Built with from their website
Shop PayGetsitecontrolShopifyReploJestHTTP/3Google Cloud FunctionsGoogle PayOpen GraphHSTS
+8 more
American ExpressGoogle Search ConsoleFacebook PixelTailwindTypeScriptTailwind CSSApple PayGoogle Cloud
- Sector
- Health
- Industry code
- NAICS 62141, 51321, 33911, SIC 8731, 7372, 3841
- Region
- New York
- Full record
- Every detail in the company directory
Health in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Aavia in front of investors. Or tell us what we have wrong.